In situ indirect fluorescent antibody: A
β
Antonio Marcos de Apparecida Levy; Elias Boainain; Judith Kardos Kloetzel
π
Article
π
1996
π
John Wiley and Sons
π
English
β 574 KB
In situ immunofluorescence assay (ISIFA) was developed for the selection fortreatment of chronically infected chagasic patients and their follow-up. Trypomastigotes flash fixed in situ on microscopic slides with 0.025% glutaraldehyde were used as antigen. ISlFA results were compared with complement-